X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (7) 7
humans (7) 7
index medicus (7) 7
phosphorylation (7) 7
cell biology (6) 6
cancer (5) 5
ubiquitination (5) 5
apoptosis (4) 4
mice (4) 4
protein-serine-threonine kinases - metabolism (4) 4
protein-tyrosine kinases - metabolism (4) 4
article (3) 3
biochemistry & molecular biology (3) 3
cell cycle (3) 3
cell line, tumor (3) 3
degradation (3) 3
dyrk2 (3) 3
e3 ligase (3) 3
female (3) 3
medical colleges (3) 3
mutation (3) 3
proteolysis (3) 3
apoptotic response (2) 2
cell differentiation (2) 2
dna damage (2) 2
dna-binding proteins - metabolism (2) 2
dna-damage (2) 2
epithelial-mesenchymal-transition (2) 2
expression (2) 2
hek293 cells (2) 2
hela cells (2) 2
histones - metabolism (2) 2
identification (2) 2
immunoblotting (2) 2
in-vitro (2) 2
kinases (2) 2
ligands (2) 2
medical prognosis (2) 2
nuclear proteins - metabolism (2) 2
p53 (2) 2
physiological aspects (2) 2
proteasome endopeptidase complex - metabolism (2) 2
protein binding (2) 2
protein-serine-threonine kinases - genetics (2) 2
protein-tyrosine kinases - genetics (2) 2
proteins (2) 2
rna interference (2) 2
tumor suppressor protein p53 - metabolism (2) 2
tumor-suppressor (2) 2
ubiquitin (2) 2
ubiquitin-protein ligases - metabolism (2) 2
14-3-3 proteins - metabolism (1) 1
analysis (1) 1
anaphase (1) 1
anaphase-promoting complex (1) 1
angiogenesis inhibitors (1) 1
animal models (1) 1
antineoplastic agents - therapeutic use (1) 1
ataxia telangiectasia mutated proteins (1) 1
b7-h1 antigen - biosynthesis (1) 1
b7-h1 antigen - metabolism (1) 1
biological phenomena, cell phenomena, and immunity (1) 1
biomarkers - metabolism (1) 1
biophysics (1) 1
breast (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - enzymology (1) 1
breast neoplasms - pathology (1) 1
breast-cancer (1) 1
c-myc (1) 1
cancer therapies (1) 1
care and treatment (1) 1
cdh1 proteins - metabolism (1) 1
cell cycle proteins - metabolism (1) 1
cell cycle regulation (1) 1
cell death (1) 1
cell division (1) 1
cell growth (1) 1
cell line (1) 1
cell nucleus - metabolism (1) 1
cell proliferation (1) 1
cell separation (1) 1
cell-growth (1) 1
cellcycle (1) 1
cells (1) 1
cercopithecus aethiops (1) 1
chemotherapy (1) 1
chromatin (1) 1
cos cells (1) 1
cullin (1) 1
cullin proteins - metabolism (1) 1
cyclin d (1) 1
cyclin d - metabolism (1) 1
cyclin g1 - metabolism (1) 1
cyclin-dependent kinase 4 (1) 1
cyclin-dependent kinase 4 - antagonists & inhibitors (1) 1
cyclin-dependent kinase 4 - metabolism (1) 1
cyclin-dependent kinase 6 - antagonists & inhibitors (1) 1
cyclin-dependent kinases (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 07/2019, Volume 571, Issue 7766, pp. E10 - E10
An Amendment to this paper has been published and can be accessed via a link at the top of the paper. The original Letter has not been corrected. 
Medical colleges | Cancer
Journal Article
Nature, ISSN 0028-0836, 1/2018, Volume 553, Issue 7686, pp. 91 - 95
Journal Article
Journal Article
Nature, ISSN 0028-0836, 01/2018, Volume 553, Issue 7686, pp. 91 - 95
Treatments that target immune checkpoints, such as the one mediated by programmed cell death protein 1 (PD-1) and its ligand PD-L1, have been approved for... 
CELLS | THERAPY | IMMUNOTHERAPY | STABILIZATION | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | RETINOBLASTOMA-PROTEIN | SPOP | DEPENDENT KINASES | BREAST | REQUIREMENT | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Immunologic Surveillance | Phosphorylation | Humans | Male | Prostatic Neoplasms - immunology | Proteolysis | Cullin Proteins - metabolism | Female | Protein Stability | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Repressor Proteins - metabolism | Tumor Escape - immunology | Cdh1 Proteins - metabolism | Lymphocytes, Tumor-Infiltrating - cytology | Cell Line | Repressor Proteins - chemistry | Programmed Cell Death 1 Receptor - metabolism | Nuclear Proteins - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Nuclear Proteins - chemistry | 14-3-3 Proteins - metabolism | B7-H1 Antigen - metabolism | Animals | Cell Cycle | Neoplasms - immunology | B7-H1 Antigen - biosynthesis | Mice | Proteasome Endopeptidase Complex - metabolism | Cyclin D - metabolism | Lymphocytes, Tumor-Infiltrating - immunology | Animal models | PD-1 protein | Kinases | Cyclin-dependent kinase 4 | Cullin | Degradation | Proteins | Ubiquitination | Cell growth | Lymphocytes | Immunotherapy | Cell cycle | Cyclin D | Ubiquitin-protein ligase | Cyclin-dependent kinases | L1 protein | Immunosurveillance | Anaphase-promoting complex | Patients | Molecular modelling | Immune checkpoint | Cell death | Medical prognosis | PD-L1 protein | Ligands | Mutation | Anaphase | Prostate cancer | Prostate | Tumors | Apoptosis | Cancer
Journal Article
Nature Cell Biology, ISSN 1465-7392, 03/2017, Volume 19, Issue 3, pp. 177 - 188
Journal Article
Science Signaling, ISSN 1945-0877, 01/2017, Volume 10, Issue 460
The SCF super([beta]-TRCP) E3 ubiquitin ligase complex plays pivotal roles in normal cellular physiology and in pathophysiological conditions. Identification... 
Journal Article
Journal Article
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 384, pp. 27 - 38
Abstract Mammalian target of rapamycin (mTOR) inhibitor, everolimus, provides benefit for metastatic hormone receptor positive breast cancer after failure of... 
Hematology, Oncology and Palliative Medicine | mTOR pathway | Breast cancer | DYRK2 | Everolimus | EPITHELIAL-MESENCHYMAL-TRANSITION | PLUS EXEMESTANE | PHOSPHORYLATION | PROTEIN-KINASE | INHIBITOR EVEROLIMUS | E3 LIGASE | IN-VITRO | ONCOLOGY | RESISTANCE | DEGRADATION | PI3K/AKT/MTOR PATHWAY | Phosphorylation | TOR Serine-Threonine Kinases - metabolism | Protein-Tyrosine Kinases - metabolism | Humans | Gene Expression Regulation, Neoplastic | Antineoplastic Agents - therapeutic use | Mechanistic Target of Rapamycin Complex 1 | Dose-Response Relationship, Drug | TOR Serine-Threonine Kinases - antagonists & inhibitors | Multiprotein Complexes - metabolism | Breast Neoplasms - enzymology | Protein-Tyrosine Kinases - genetics | Ubiquitination | TOR Serine-Threonine Kinases - genetics | Transfection | MCF-7 Cells | RNA Interference | Time Factors | Proteolysis | Everolimus - therapeutic use | Female | Protein-Serine-Threonine Kinases - metabolism | Down-Regulation | Protein-Serine-Threonine Kinases - genetics | Breast Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Tumor Burden - drug effects | Breast Neoplasms - pathology | Mice, Nude | Protein Kinase Inhibitors - therapeutic use | Mutation | Proteasome Endopeptidase Complex - metabolism | Ubiquitin | Tyrosine | Medical colleges | Analysis | Metastasis | Angiogenesis inhibitors | Hormones | Medical research | Endocrine therapy | Cytotoxicity | FDA approval | Kinases | Gene expression | Cancer therapies | Data bases | Studies | Proteins | Chemotherapy | Plasmids | Rodents | Medical prognosis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.